![]() |
| Source: 3D Systems Q1 2026 Earnings Report |
DentalGoodNews|On May 11, 2026, 3D Systems (NYSE:DDD) released its first-quarter 2026 earnings report. The company reported total revenue of $95.5 million for the period, a year-over-year increase of 1% (or 11% excluding the impact of the 2025 software divestiture). Net Profit Attributable to Shareholders of the Parent Company was a loss of $4.4 million, narrowing by 88.11% year-over-year. During the period, the company's non-GAAP Adjusted EBITDA was $2.1 million, turning profitable compared to a loss of $23.9 million in the same period last year.
By segment, Healthcare Solutions recorded revenue of $50.1 million, up approximately 21% from $41.3 million in the same period last year. Among them, the Dental and Med Tech businesses performed strongly, both with year-over-year growth exceeding 20%. The company stated that due to the rapid expansion of its healthcare business, its scale is now close to that of the Industrial segment.
In the dental field, the company noted that its recently launched advanced printing system for Monolithic dentures has achieved early market success, further supporting the long-term growth of the dental business. According to previous reports by DENTALGOODNEWS (Leading Dental Industry Media, DGN), 3D Systems disclosed in its full-year 2025 financial report that its dental business achieved double-digit sequential growth in the fourth quarter, primarily driven by new denture technology.
In contrast, the company's Industrial Solutions segment recorded revenue of $45.4 million in the first quarter, down approximately 15% from $53.2 million in the same period last year. This decline was mainly due to the software business divestiture completed in 2025 (including Geomagic, 3DXpert, and Oqton). Excluding the divestiture impact, the industrial business actually grew 2% year-over-year.
In terms of profitability, GAAP gross margin for the first quarter rose to 35.9% from 34.6% in the same period last year; non-GAAP gross margin was 36.1%. The company attributed the margin improvement to higher sales, an optimized revenue mix, and the continued execution of cost reduction initiatives.
As of March 31, 2026, the company held total cash of $86.5 million, including $85.1 million in cash and cash equivalents and $1.4 million in restricted cash. Looking ahead to the second quarter, the company expects revenue to be between $93 million and $95 million, with Adjusted EBITDA projected to be a loss of $2 million to $4 million.
| About DGN:DentalGoodNews (DGN) is a trusted professional media platform dedicated to the global dental industry. We deliver in-depth coverage of corporate news, policy & regulation, investment & funding, and clinical frontiers — serving dental institutions, device manufacturers, investors, and industry researchers worldwide. Contact us: haodeya@dongxizixun.com |